Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 221.00
Bid: 221.00
Ask: 222.50
Change: -1.50 (-0.67%)
Spread: 1.50 (0.679%)
Open: 222.50
High: 225.00
Low: 219.00
Prev. Close: 222.50
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PureTech's Vedanta BioSciences Raises USD50 Million To Advance Studies

Mon, 06th Jun 2016 06:40

LONDON (Alliance News) - PureTech Health PLC on Monday said its subsidiary Vedanta BioSciences has raised USD50 million to help advance a number of studies in infectious and autoimmune diseases, and to build its technology platform.

Vedanta Biosciences its developing a new class of therapies designed to modulate the human microbiome. Investors in the funding round included new investors Rock Springs Capital Management, Invesco Asset Management, and Health for Life Capital.

PureTech contributed USD30 million to the funding, taking its total stake in Vedanta to over 75%. Invesco invested USD11 million, and as Invesco is a 32% shareholder in PureTech, this investment is considered a smaller related-party transaction.

"We are grateful for the strong support from venture and leading public healthcare investors who share our vision to take the microbiome field beyond faecal transplants and into rationally defined bacterial consortia," said Chief Executive Officer of Vedanta Biosciences Bernat Olle in a statement.

"This financing positions us to advance multiple candidates that have emerged from our discovery platform into clinical trials," Olle added.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
18 May 2020 13:46

UK DIRECTOR DEALINGS SUMMARY: Novacyt Chair And CEO Step In To Buy

UK DIRECTOR DEALINGS SUMMARY: Novacyt Chair And CEO Step In To Buy

Read more
9 Apr 2020 12:54

PureTech Health Swings To Annual Profit On Exceptional Gains

PureTech Health Swings To Annual Profit On Exceptional Gains

Read more
9 Apr 2020 09:09

Puretech Health revenues slide, losses widen

(Sharecast News) - Clinical-stage biotherapeutics company Puretech Health posted weaker full-year revenues and a widened operating loss on Thursday and also noted it was yet to see any impact to ongoing work as a result of the Covid-19 outbreak.

Read more
2 Apr 2020 16:09

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
3 Mar 2020 16:07

PureTech Health Doses First Patient In Phase 1 LYT-100 Study

PureTech Health Doses First Patient In Phase 1 LYT-100 Study

Read more
3 Mar 2020 08:04

PureTech begins next study of lymphoedema drug candidate

(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health announced on Tuesday that the first participant has been dosed in a clinical study of 'LYT-100', its wholly-owned product candidate for the potential treatment of lymphoedema and other fibrotic conditions.

Read more
25 Feb 2020 14:10

PureTech Health Affiliate Akili Posts Encouraging ADHD Study Results

PureTech Health Affiliate Akili Posts Encouraging ADHD Study Results

Read more
24 Jan 2020 12:45

Friday broker round-up

(Sharecast News) - TT Electronics: Jefferies downgrades to hold with a target price of 265p.

Read more
23 Jan 2020 07:44

PureTech sells shares in Karuna affiliate for $200m

(Sharecast News) - Clinical stage biotech company PureTech Health said it had sold 2.1m shares of its affiliate Karuna Therapeutics for $200m.

Read more
15 Jan 2020 13:26

PureTech Health Unit Akili's AKL-T01 Study Achieves Primary Endpoint

PureTech Health Unit Akili's AKL-T01 Study Achieves Primary Endpoint

Read more
19 Dec 2019 17:33

PureTech Health Affiliate Reports Positive Results In Alopecia Study

PureTech Health Affiliate Reports Positive Results In Alopecia Study

Read more
19 Dec 2019 08:25

PureTech affiliate Follica reports 44% improvement in hair-loss study

(Sharecast News) - PureTech Health on Thursday said results from a study into a hair loss treatment developed by its affiliate Follica demonstrated a statistically significant 44% improvement in hair count.

Read more
17 Dec 2019 16:13

PureTech's Gelesis Partners With Telehealth Firm Ro For Plenity In US

PureTech's Gelesis Partners With Telehealth Firm Ro For Plenity In US

Read more
12 Dec 2019 15:52

PureTech Health Investee Akili Delivers Positive AKL-T03 Trial Results

PureTech Health Investee Akili Delivers Positive AKL-T03 Trial Results

Read more
10 Dec 2019 14:47

PureTech Health's Vedanta Launches First-In-Patient Study Of VE800

PureTech Health's Vedanta Launches First-In-Patient Study Of VE800

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.